MSF Capital’s Amgen AMGN Stock Holding History

MSF Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,061	Closed	-$2.36M	–	21
2015 Q3	$2.36M	Hold	17,061	–	–	0.61%	29
2015 Q2	$2.62M	Hold	17,061	–	–	0.63%	29
2015 Q1	$2.73M	Hold	17,061	–	–	0.68%	26
2014 Q4	$2.72M	Hold	17,061	–	–	0.65%	27
2014 Q3	$2.4M	Hold	17,061	–	–	0.56%	32
2014 Q2	$2.02M	Sell	17,061 -550	-3%	-$63.7K	0.46%	34
2014 Q1	$2.17M	Hold	17,611	–	–	0.49%	33
2013 Q4	$2.01M	Buy	17,611 +550	+3%	+$62.6K	0.46%	35
2013 Q3	$1.91M	Buy	+17,061	New	+$1.85M	0.46%	34
2013 Q2	–	Hold	0	–	–	–	37

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

MSF Capital's AMGN Position: Q4 2015 in Review

MSF Capital sold out of Amgen (AMGN) in Q4 2015, closing a stake of 17,061 shares — an estimated $2.36M sold.

MSF Capital first reported a position in AMGN in Q3 2013 and held it in 9 quarters. The position peaked at $2.73M in Q1 2015. 1,455 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

MSF Capital reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
MSF Capital sold 17,061 Amgen shares in Q4 2015, an estimated $2.36M.
MSF Capital first reported a position in Amgen in Q3 2013 and held it in 9 quarters.
MSF Capital's Amgen position peaked at $2.73M in Q1 2015.
1,455 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on MSF Capital's 13F filing for Q4 2015, filed 11 Feb 2016.